Acclaimed organization calls for overhaul of clinical trials program

The Institute of Medicine (IOM) is calling for a complete overhaul of the National Cancer Institute’s Clinical Trials Cooperative Group Program, saying that there are plenty of reasons to believe that "the program is falling short of its potential to conduct the timely, large-scale, innovative trials needed to improve patient care." If the program doesn't become leaner and more effective, the IOM believes that "improved treatments for cancer will be delayed and patient lives will be lost."

FINDINGS

The report, A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, itemizes four ways to re-energize the program:

- Improve the speed, efficiency of the design, launch and conduct of clinical trials.
- Improve selection, prioritization, support and completion of clinical trials.
- Encourage expanded participation by both patients and physicians.
- Make the best use of scientific innovations.

COMMENTARY

Calling the Clinical Trials Cooperative Group Program "the jewel of our nation’s cancer research system" and saying that most of what is known about cancer treatment derives from this program, the former president of the American Society of Clinical Oncology (ASCO) released a statement on behalf of the ASCO fully supporting the IOM.

By Ross Bonander

Source: HemOnctoday

More Articles

More Articles

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...